Rouba Kozak - Publications

Pfizer, Trujui, Buenos Aires, Argentina 

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Kozak R, Kiss T, Dlugolenski K, Johnson DE, Gorczyca RR, Kuszpit K, Harvey BD, Stolyar P, Sukoff Rizzo SJ, Hoffmann WE, Volfson D, Hajós M, Davoren JE, Abbott AL, Williams GV, et al. Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation. Frontiers in Pharmacology. 11: 1005. PMID 32733245 DOI: 10.3389/Fphar.2020.01005  0.92
2020 Young D, Popiolek M, Trapa P, Fonseca KR, Brevard J, Gray DL, Kozak R. D1 agonist improved movement of parkinsonian nonhuman primates with limited dyskinesia side effects. Acs Chemical Neuroscience. PMID 31971364 DOI: 10.1021/acschemneuro.9b00589  0.92
2020 Soutschek A, Kozak R, de Martinis N, Howe W, Burke CJ, Fehr E, Jetter A, Tobler PN. Activation of D1 receptors affects human reactivity and flexibility to valued cues. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31962344 DOI: 10.1038/S41386-020-0617-Z  0.72
2018 Popiolek M, Mandelblat-Cerf Y, Young D, Garst-Orozco J, Lotarski SM, Stark E, Kramer M, Butler CR, Kozak R. In vivo modulation of hippocampal excitability by M4 muscarinic acetylcholine receptor activator: implications for treatment of Alzheimer's disease and schizophrenic patients. Acs Chemical Neuroscience. PMID 30335349 DOI: 10.1021/acschemneuro.8b00496  0.92
2018 Howe WM, Brooks JL, Tierney PL, Pang J, Rossi A, Young D, Dlugolenski K, Guillmette E, Roy M, Hales K, Kozak R. α5 nAChR modulation of the prefrontal cortex makes attention resilient. Brain Structure & Function. PMID 29299690 DOI: 10.1007/s00429-017-1601-1  1
2016 Howe WM, Young DA, Bekheet G, Kozak R. Nicotinic receptor subtypes differentially modulate glutamate release in the dorsal medial striatum. Neurochemistry International. PMID 27568861 DOI: 10.1016/j.neuint.2016.08.009  1
2015 Mohler EG, Ding Z, Rueter LE, Chapin D, Young D, Kozak R. Cross-site strain comparison of pharmacological deficits in the touchscreen visual discrimination test. Psychopharmacology. PMID 26177580 DOI: 10.1007/s00213-015-4012-0  1
2015 Yohn SE, Santerre JL, Nunes EJ, Kozak R, Podurgiel SJ, Correa M, Salamone JD. The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists. Pharmacology, Biochemistry, and Behavior. 135: 217-26. PMID 26022661 DOI: 10.1016/J.Pbb.2015.05.003  1
2015 Howe WM, Tierney PL, Young DA, Oomen C, Kozak R. MAM (E17) rodent developmental model of neuropsychiatric disease: disruptions in learning and dysregulation of nucleus accumbens dopamine release, but spared executive function. Psychopharmacology. PMID 25963563 DOI: 10.1007/s00213-015-3955-5  1
2015 Howe W, Tierney PL, Rossi A, Young D, Guillmette E, Kozak R. 2.14α5 nAChR modulation of the effects of nicotine on ventral-striatal DA release and cue-reward learning Biochemical Pharmacology. 97: 634-635. DOI: 10.1016/J.Bcp.2015.08.039  0.92
2014 Kozak R, Campbell BM, Strick CA, Horner W, Hoffmann WE, Kiss T, Chapin DS, McGinnis D, Abbott AL, Roberts BM, Fonseca K, Guanowsky V, Young DA, Seymour PA, Dounay A, et al. Reduction of brain kynurenic acid improves cognitive function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 10592-602. PMID 25100593 DOI: 10.1523/Jneurosci.1107-14.2014  1
2014 Koshy Cherian A, Gritton H, Johnson DE, Young D, Kozak R, Sarter M. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats. Neuropharmacology. 82: 41-8. PMID 24647121 DOI: 10.1016/j.neuropharm.2014.03.004  1
2013 Lustig C, Kozak R, Sarter M, Young JW, Robbins TW. CNTRICS final animal model task selection: control of attention. Neuroscience and Biobehavioral Reviews. 37: 2099-110. PMID 22683929 DOI: 10.1016/J.Neubiorev.2012.05.009  1
2010 Lowe JA, DeNinno SL, Coe JW, Zhang L, Mente S, Hurst RS, Mather RJ, Ward KM, Shrikhande A, Rollema H, Johnson DE, Horner W, Gorczyca R, Tingley FD, Kozak R, et al. A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6/4beta4 nicotinic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 20: 4749-52. PMID 20663668 DOI: 10.1016/j.bmcl.2010.06.142  1
2009 Rollema H, Hajós M, Seymour PA, Kozak R, Majchrzak MJ, Guanowsky V, Horner WE, Chapin DS, Hoffmann WE, Johnson DE, McLean S, Freeman J, Williams KE. Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. Biochemical Pharmacology. 78: 813-24. PMID 19501054 DOI: 10.1016/J.Bcp.2009.05.033  1
2009 Sarter M, Martinez V, Kozak R. A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia. Psychopharmacology. 202: 237-58. PMID 18618100 DOI: 10.1007/s00213-008-1216-6  1
2008 Ji C, Li W, Ren XD, El-Kattan AF, Kozak R, Fountain S, Lepsy C. Diethylation labeling combined with UPLC/MS/MS for simultaneous determination of a panel of monoamine neurotransmitters in rat prefrontal cortex microdialysates. Analytical Chemistry. 80: 9195-203. PMID 19551941 DOI: 10.1021/Ac801339Z  1
2007 Parikh V, Kozak R, Martinez V, Sarter M. Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron. 56: 141-54. PMID 17920021 DOI: 10.1016/j.neuron.2007.08.025  1
2007 Kozak R, Martinez V, Young D, Brown H, Bruno JP, Sarter M. Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2074-86. PMID 17299502 DOI: 10.1038/sj.npp.1301352  1
2006 Sarter M, Bruno JP, Parikh V, Martinez V, Kozak R, Richards JB. Forebrain dopaminergic-cholinergic interactions, attentional effort, psychostimulant addiction and schizophrenia. Exs. 98: 65-86. PMID 17019883  1
2006 Parikh V, Apparsundaram S, Kozak R, Richards JB, Sarter M. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice. Neuroscience. 141: 379-89. PMID 16675138 DOI: 10.1016/J.Neuroscience.2006.03.055  1
2006 Sarter M, Gehring WJ, Kozak R. More attention must be paid: the neurobiology of attentional effort. Brain Research Reviews. 51: 145-60. PMID 16530842 DOI: 10.1016/j.brainresrev.2005.11.002  1
2006 Beck B, Kozak R, Moar KM, Mercer JG. Hypothalamic orexigenic peptides are overexpressed in young Long-Evans rats after early life exposure to fat-rich diets. Biochemical and Biophysical Research Communications. 342: 452-8. PMID 16487482 DOI: 10.1016/j.bbrc.2006.01.158  1
2006 Kozak R, Bruno JP, Sarter M. Augmented prefrontal acetylcholine release during challenged attentional performance. Cerebral Cortex (New York, N.Y. : 1991). 16: 9-17. PMID 15788700 DOI: 10.1093/cercor/bhi079  1
2005 Kozak R, Richy S, Beck B. Persistent alterations in neuropeptide Y release in the paraventricular nucleus of rats subjected to dietary manipulation during early life. The European Journal of Neuroscience. 21: 2887-92. PMID 15926937 DOI: 10.1111/j.1460-9568.2005.04101.x  1
2005 Apparsundaram S, Martinez V, Parikh V, Kozak R, Sarter M. Increased capacity and density of choline transporters situated in synaptic membranes of the right medial prefrontal cortex of attentional task-performing rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 3851-6. PMID 15829637 DOI: 10.1523/Jneurosci.0205-05.2005  1
2005 Kozak R, Bowman EM, Latimer MP, Rostron CL, Winn P. Excitotoxic lesions of the pedunculopontine tegmental nucleus in rats impair performance on a test of sustained attention. Experimental Brain Research. 162: 257-64. PMID 15558253 DOI: 10.1007/S00221-004-2143-3  1
2004 Taylor CL, Kozak R, Latimer MP, Winn P. Effects of changing reward on performance of the delayed spatial win-shift radial maze task in pedunculopontine tegmental nucleus lesioned rats. Behavioural Brain Research. 153: 431-8. PMID 15265639 DOI: 10.1016/j.bbr.2003.12.019  1
2001 Alderson HL, Jenkins TA, Kozak R, Latimer MP, Winn P. The effects of excitotoxic lesions of the pedunculopontine tegmental nucleus on conditioned place preference to 4%, 12% and 20% sucrose solutions. Brain Research Bulletin. 56: 599-605. PMID 11786248 DOI: 10.1016/S0361-9230(01)00733-X  1
2000 Kozak R, Burlet A, Burlet C, Beck B. Dietary composition during fetal and neonatal life affects neuropeptide Y functioning in adult offspring. Brain Research. Developmental Brain Research. 125: 75-82. PMID 11154763 DOI: 10.1016/S0165-3806(00)00120-6  1
1998 Kozak R, Mercer JG, Burlet A, Moar KM, Burlet C, Beck B. Hypothalamic neuropeptide Y content and mRNA expression in weanling rats subjected to dietary manipulations during fetal and neonatal life. Regulatory Peptides. 75: 397-402. PMID 9802435 DOI: 10.1016/S0167-0115(98)00094-9  1
1998 Beck B, Kozak R, Stricker-Krongrad A, Burlet C. Neuropeptide Y release in the paraventricular nucleus of Long-Evans rats treated with leptin. Biochemical and Biophysical Research Communications. 242: 636-9. PMID 9464269 DOI: 10.1006/bbrc.1997.8021  1
1997 Stricker-Krongrad A, Kozak R, Burlet C, Nicolas JP, Beck B. Physiological regulation of hypothalamic neuropeptide Y release in lean and obese rats. The American Journal of Physiology. 273: R2112-6. PMID 9435668  1
1996 Simonneaux V, Kozak R, Arsenijévic Y, Pévet P. Vasopressin potentiation of the melatonin synthetic pathway via specific V1a receptors in the rat pineal gland. Regulatory Peptides. 61: 63-9. PMID 8701029 DOI: 10.1016/0167-0115(95)00139-5  1
Show low-probability matches.